Radiofrequency Ablation Devices Market Overview, Growth, Trends, Analysis, Research Report (2021-2031)

The radiofrequency ablation devices market size in 2021 stood at US$ 3.93 billion and is projected to reach US$ 12.08 billion by 2031 from US$ XX billion in 2023. The market is expected to register a CAGR of 12.2% in 2023–2031. Integration of cutting-edge technology in ablation devices is likely to remain a key radiofrequency ablation device market trend.

Radiofrequency Ablation Devices Market Analysis

Radiofrequency devices are widely used in cancer treatment, cardiology, gynecology, cosmetology, and pain management. There has been an increase in the demand for radiofrequency due to the growing prevalence of cardiovascular disorders, particularly atrial fibrillation, and increasing preference for minimally invasive procedures. Radiofrequency devices have a high success rate for the treatment of artial fibrillation which has enhanced product adoption and favored the market growth.

Radiofrequency Ablation Devices Market Overview

Radiofrequency ablation is an interventional method that has been used in a variety of medical sectors, including the treatment of cardiac arrhythmias and the removal of tumors in various sites. Manufacturers are creating ablation devices capable of destroying specific or diseased tissues using technologies such as radio frequency, robotic-assisted operations, electrical, ultrasound, and laser. Ablation devices have become a popular and effective treatment for chronic bronchitis, cancer, irregular heartbeats, and nerve discomfort.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Radiofrequency Ablation Devices Market: Strategic Insights

Radiofrequency Ablation Devices Market

• 
  CAGR (2023 - 2031)

  12.2%
• Market Size 2021
  US$ 3.93 Billion
• Market Size 2031
  US$ 12.08 Billion

Market Dynamics

GROWTH DRIVERS

• Increasing Prevalence of Chronic Diseases Growing Applications of Radiofrequency Ablation Technology

FUTURE TRENDS

• New Product Launches

OPPORTUNITIES

• Integration of Cutting-Edge Technology in Ablation Devices

Key Players

• Avanos Medical Inc
• Stryker
• Abbott
• Medtronic
• Boston Scientific
• Bard BD
• Angiodynamic
• Hologic
• Articure
• Merit medical

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product

• Devices
• Disposables

Application

• Surgical Oncology
• Cardiology
• Gynecology
• Cosmetology
• Pain Management

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Radiofrequency Ablation Devices Market Drivers and Opportunities

Growing Applications to Drive the Radiofrequency Ablation Technology Market

In recent years, the technique is also used for treating patients suffering from adrenal gland, liver, breast, bone, pancreatic, kidney, lung, and thyroid cancer, although it is not a primary treatment for cancer. In addition to oncology, radiofrequency ablation technology is also being used to treat patients with cardiac conditions, when medicines or other treatments fail to cure these conditions.

New Product Launches offers Lucrative Opportunities

The players in the radiofrequency ablation devices market are coming up with multiple and advanced products for radiofrequency ablation procedures. For instance, in March 2024, NeuroOne Medical Technologies has initiated a limited commercial launch of its OneRF ablation system, which has US Food and Drug Administration (FDA) 510(k) clearance for creation of radiofrequency (RF) lesions in nervous tissue for the functional neurosurgical procedures.

Radiofrequency Ablation Devices Market Report Segmentation Analysis

Key segments that contributed to the derivation of the radiofrequency ablation devices market analysis are product and application.

• Based on product, the radiofrequency ablation devices market is bifurcated into devices and disposables. The disposables segment held a larger market share in 2023.
• By application, the market is segmented into surgical oncology, cardiology, cosmetology, gynecology, and pain management. The surgical oncology segment held the largest share of the market in 2023.

Radiofrequency Ablation Devices Market Share Analysis by Geography

The geographic scope of the radiofrequency ablation devices Market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the radiofrequency ablation devices market. Increasing cases of chronic diseases like cardiovascular diseases, and cancer, increasing competition between the market players, and high R&D spending are some of the major factors driving the market growth in North America.  

Radiofrequency Ablation Devices Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Radiofrequency Ablation Devices Market News and Recent Developments

The radiofrequency ablation devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for radiofrequency ablation devices market:

• AtriCure, Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, announced that it has launched the EnCompass Clamp, a part of the Isolator Synergy Ablation System in the United States. The EnCompass Clamp received FDA 510(k) clearance for ablation of cardiac tissue during cardiac surgery and is designed to make concomitant surgical ablations more efficient. (Source: ATRICURE, INC., Press Release, 2022)
• BD (Becton, Dickinson, and Company), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that is the result of malfunctioning valves and can lead to varicose veins. (Source: BD, Press Release, 2021)

Radiofrequency Ablation Devices Market Report Coverage and Deliverables

The “Radiofrequency Ablation Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles